Author Index
Search or browse for an author across our entire electronic archive
Search results for: O
Results 31 - 40 of 688 shown below
O'Brien, P H
E F McClay, M E T McClay, L Monroe, P L Baron, D J Cole, P H O'Brien, J S Metcalf and J C Maize
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma
doi:10.1054/bjoc.1999.1220
O'Byrne, K
D J Propper, N C Levitt, K O'Byrne, J P Braybrooke, D C Talbot, T S Ganesan, C H Thompson, B Rajagopalan, T J Littlewood, R M Dixon and A L Harris
Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer
doi:10.1054/bjoc.2000.1138
-
D J Propper, J P Braybrooke, N C Levitt, K O'Byrne, K Christodoulos, C Han, D C Talbot, T S Ganesan and A L Harris
Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine
doi:10.1054/bjoc.2000.1141
O'Byrne, K J
K J O'Byrne, N Dobbs, K Mitchell, J Woodhull and A L Harris
Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer
doi:10.1038/sj.bjc.6690226
-
K J O'Byrne, N Dobbs and A L Harris
Serum vascular endothelial growth factor load and interleukin-6 in cancer patients
doi:10.1054/bjoc.1999.1115
-
K J O'Byrne, M I Koukourakis, A Giatromanolaki, G Cox, H Turley, W P Steward, K Gatter and A L Harris
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
doi:10.1054/bjoc.1999.1129
-
J P Braybrooke, D J Propper, K J O'Byrne, M I Koukourakis, A V Patterson, S Houlbrook, S D Love, S Varcoe, M Taylor, T S Ganesan, D C Talbot and A L Harris
Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha
doi:10.1054/bjoc.2000.1230
-
K J O'Byrne and A G Dalgleish
Chronic immune activation and inflammation as the cause of malignancy
doi:10.1054/bjoc.2001.1943
-
J G Edwards, G Cox, A Andi, J L Jones, R A Walker, D A Waller and K J O'Byrne
Angiogenesis is an independent prognostic factor in malignant mesothelioma
doi:10.1054/bjoc.2001.1997
O'Connell, M
S Jefferies, R Eeles, D Goldgar, R A'Hern, M Gore, D Archer, K Bishop, A Murkin, E Solomon, S Hodgsun, M O'Connell, J Hibbert, D Easton and W Foulkes
The role of genetic factors in predisposition to squamous cell cancer of the head and neck
doi:10.1038/sj.bjc.6690138
O'Doherty, C A
J Shamash, R T D Oliver, C J Gallagher, A C Newland, T A Lister, S Kelsey, R K Gupta and C A O'Doherty
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
doi:10.1054/bjoc.1999.1140
O'Doherty, M J
S F Hain, M J O'Doherty, A R Timothy, M D Leslie, P G Harper and R A Huddart
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
doi:10.1054/bjoc.2000.1389
O'Donnell, M
A F West, M O'Donnell, R G Charlton, D E Neal and H Y Leung
Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer
doi:10.1054/bjoc.2001.1971
O'Donoghue, D P
H J N Andreyev, A R Norman, D Cunningham, J Oates, B R Dix, B J Iacopetta, J Young, T Walsh, R Ward, N Hawkins, M Beranek, P Jandik, R Benamouzig, E Jullian, P Laurent-Puig, S Olschwang, O Muller, I Hoffmann, H M Rabes, C Zietz, C Troungos, C Valavanis, S T Yuen, J W C Ho, C T Croke, D P O'Donoghue, W Giaretti, A Rapallo, A Russo, V Bazan, M Tanaka, K Omura, T Azuma, T Ohkusa, T Fujimori, Y Ono, M Pauly, C Faber, R Glaesener, A F P M de Goeij, J W Arends, S N Andersen, T Lövig, J Breivik, G Gaudernack, O P F Clausen, P De Angelis, G I Meling, T O Rognum, R Smith, H-S Goh, A Font, R Rosell, X F Sun, H Zhang, J Benhattar, L Losi, J Q Lee, S T Wang, P A Clarke, S Bell, P Quirke, V J Bubb, J Piris, N R Cruickshank, D Morton, J C Fox, F Al-Mulla, N Lees, C N Hall, D Snary, K Wilkinson, D Dillon, J Costa, V E Pricolo, S D Finkelstein, J S Thebo, A J Senagore, S A Halter, S Wadler, S Malik, K Krtolica and N Urosevic
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study
doi:10.1054/bjoc.2001.1964
O'Dorisio, M S
J C Watson, D A Balster, B M Gebhardt, T M O'Dorisio, M S O'Dorisio, G D Espenan, G J Drouant and E A Woltering
Growing vascular endothelial cells express somatostatin subtype 2 receptors
doi:10.1054/bjoc.2001.1881
O'Dorisio, T M
J C Watson, D A Balster, B M Gebhardt, T M O'Dorisio, M S O'Dorisio, G D Espenan, G J Drouant and E A Woltering
Growing vascular endothelial cells express somatostatin subtype 2 receptors
doi:10.1054/bjoc.2001.1881
